US Industry & Ecosystem Lead, Life Sciences

Quick Facts

• Role: US Industry & Ecosystem Lead (Life Sciences)

Description

Own the U.S. life sciences strategy across pharma and medical devices, with the manufacturing floor as the initial beachhead for scalable modernization. Deliver capabilities such as line-side iPad, electronic batch records, device history records, paperless quality, MES/manufacturing execution modernization, and regulatory data integrity for GMP production. Grow the partner ecosystem and act as the life sciences authority inside Apple, translating Pharma 4.0, GxP-validated AI, and evolving FDA AI/ML guidance into strategic initiatives.

Responsibilities

• Uncover and deliver manufacturing modernization connecting the GMP floor with MES, quality, and manufacturing-execution platforms

• Advance GxP-validated AI using on-device intelligence and AI-assisted workflows that meet regulatory standards

• Grow the life sciences partner ecosystem (pharma/biotech/medtech, CROs, MES/quality-platform partners, ISVs, systems integrators) into repeatable, scalable wins

• Shape Apple’s life sciences position and secure executive buy-in for major bets

• Scale priority use cases beyond manufacturing (e.g., field sales enablement and Apple as a controller for implantable devices)

• Engage regulatory bodies and standards organizations, including FDA’s evolving AI/ML guidance

• Partner with product, engineering, privacy, and legal teams as the industry voice inside Apple

Requirements

• 15+ years at the intersection of technology and life sciences (industry, consulting, or key ISV)

• Direct experience with regulated manufacturing in pharma or medical devices (GMP plant floors, quality systems, validated environments)

• Proven track record building life sciences partner ecosystems and scaling repeatable business outcomes

• Bachelor’s degree or equivalent experience

Benefits

• Opportunity to transform regulated manufacturing and scale repeatable deployments across industry plants

• Strategic role influencing life sciences frameworks, partner ecosystems, and executive decisions